Longevity Health Holdings, Inc. Common Stock
XAGE
XAGE was delisted on the 11th of September, 2025.
40 hedge funds and large institutions have $132M invested in Longevity Health Holdings, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 5 closing their positions.
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
3% more funds holding
Funds holding: 39 → 40 (+1)
3% more capital invested
Capital invested by funds: $128M → $132M (+$4.43M)
0.03% more ownership
Funds ownership: 2.7% → 2.73% (+0.03%)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$11.2M |
| 2 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$2.78M |
| 3 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$2.51M |
| 4 |
CIM
Cowen Investment Management
New York
|
+$1.46M |
| 5 |
ETH
Exos TFP Holdings
New York
|
+$541K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sculptor Capital
New York
|
-$14.6M |
| 2 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$1.05M |
| 3 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$882K |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$167K |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$167K |
XAGE Hedge Fund Activity: Q1 2023 in Review
40 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Longevity Health Holdings, Inc. Common Stock (XAGE) for Q1 2023, worth a combined $132M — up 3.5% from $128M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new XAGE positions and 5 closed out — a net gain of 1 holder — while 4 added to existing stakes and 7 trimmed.
The largest buyer was JP Morgan Chase, opening a new position worth an estimated $11.2M. The largest seller was Sculptor Capital, exiting entirely with an estimated $14.6M sold.
- 40 institutional investors held Longevity Health Holdings, Inc. Common Stock (XAGE) as of Q1 2023, up from 39 in Q4 2022.
- Funds reported $132M of Longevity Health Holdings, Inc. Common Stock stock for Q1 2023, up 3.5% quarter-over-quarter.
- 6 funds opened new Longevity Health Holdings, Inc. Common Stock positions in Q1 2023 and 5 closed out, a net change of +1 holder.
- The largest Longevity Health Holdings, Inc. Common Stock buyer in Q1 2023 was JP Morgan Chase, an estimated $11.2M added.
- The largest Longevity Health Holdings, Inc. Common Stock seller in Q1 2023 was Sculptor Capital, an estimated $14.6M sold.
Based on aggregated 13F filings for Q1 2023.